Envista Holdings CorpEnvista Holdings Corp
Envista Holdings Corp

Envista Holdings Corp

NVST
Health Care·Health Care Equipment & Supplies

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It offers dental consumables, equipment, and services to dental professionals. It operates through the Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures, and markets dental implant systems, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments refers to developing, manufacturing, and marketing dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization and magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems, and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. The company was founded on August 29, 2018 and is headquartered in Brea, CA.

California; U.S.A
Market cap
No dataNo data
Revenue
$2.7B+8.3% YoY
Net income
$47M+104.2% YoY
Free cash flow
$230.4M−23.9% YoY

Market

Listed stock
NVSTPriceNYSE
Loading…Loading…1Y

Financial performance

Revenue
$2.7B+8.3% YoY
Operating income
$216.1M+120.8% YoY
Net income
$47M+104.2% YoY
Free cash flow
$230.4M−23.9% YoY

Revenue, profit & cash trend

Revenue
Operating income
Net income
Free cash flow
Reference
Revenue: 2021 $2.5B, 2022 $2.6B, 2023 $2.6B, 2024 $2.5B, 2025 $2.7B. Operating income: 2021 $306.2M, 2022 $319.2M, 2023 $31.5M, 2024 $-1B, 2025 $216.1M. Net income: 2021 $340.5M, 2022 $243.1M, 2023 $-100.2M, 2024 $-1.1B, 2025 $47M. Free cash flow: 2021 $306.9M, 2022 $107M, 2023 $217.5M, 2024 $302.7M, 2025 $230.4M. Reference line: Reference at $0.

Growth & profitability

Revenue growth
8.3%+1050 bps YoY
Gross margin
No dataNo data
Operating margin
No dataNo data
FCF margin
No dataNo data

Earnings power over time

Operating income
Net income
Free cash flow
Operating income: 2021-12-31 $306.2M, 2022-12-31 $319.2M, 2023-12-31 $31.5M, 2024-12-31 $-1B, 2025-12-31 $216.1M. Net income: 2021-12-31 $340.5M, 2022-12-31 $243.1M, 2023-12-31 $-100.2M, 2024-12-31 $-1.1B, 2025-12-31 $47M. Free cash flow: 2021-12-31 $306.9M, 2022-12-31 $107M, 2023-12-31 $217.5M, 2024-12-31 $302.7M, 2025-12-31 $230.4M

Growth heatmap

2022202320242025CAGR
Revenue
+2.4%
-0.1%
-2.2%
+8.3%
+2.0%
Gross profit
+3.4%
-2.3%
-4.7%
+8.3%
+1.0%
Operating income
+4.2%
-90.1%
-3395.9%
+120.8%
-8.3%
Free cash flow
-65.1%
+103.3%
+39.2%
-23.9%
-6.9%

Earnings quality

Operating cash flow
$275.7M−18.1% YoY
Net income
$47M+104.2% YoY
Free cash flow
$230.4M−23.9% YoY
Diluted EPS
No dataNo data

Cash conversion quality

Operating cash flow
Free cash flow
Net income = 100%
Operating cash flow: 2025-12-31 587%, 2024-12-31 -30%, 2023-12-31 -275%, 2022-12-31 75%, 2021-12-31 106%. Free cash flow: 2025-12-31 490%, 2024-12-31 -27%, 2023-12-31 -217%, 2022-12-31 44%, 2021-12-31 90%. Reference line: Net income = 100% at 100%.

Per-share economics

Diluted EPS
Latest
No data
FCF / share
Latest
No data
Diluted shares
Latest
No data

Financial flexibility

Cash & equivalents
No dataNo data
Total debt
No dataNo data
Net debt
No dataNo data
Current ratio
No dataNo data

Cash Coverage of Debt

Cash / Total debt
No data

Returns

Return on equity
No dataNo data
Return on assets
No dataNo data
Return on invested capital
No dataNo data
Asset turnover
No dataNo data

Return on capital

No data

Valuation

Price to earnings
No dataNo data
Price to sales
No dataNo data
EV / EBITDA
No dataNo data
Free cash flow yield
No dataNo data

Valuation vs its own 5Y history

Metric
Own five-year range
Current
Own 5Y median
Position in own range
Price to earnings
No data
No data
No data
No data
Price to sales
No data
No data
No data
No data
EV / EBITDA
No data
No data
No data
No data
Free cash flow yield
No data
No data
No data
No data